cas 1951439-42-1|| where to buy 3-((2-Chloropyridin-4-yl)methyl)-1-cyclobutyl-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c]isoquinolin-5(4H)-one

Nom du produit:3-((2-Chloropyridin-4-yl)methyl)-1-cyclobutyl-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c]isoquinolin-5(4H)-one

IUPAC Name:3-[(2-chloropyridin-4-yl)methyl]-1-cyclobutyl-3H,4H,5H,6H,7H,8H,9H-pyrazolo[3,4-c]isoquinolin-5-one

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM228812-1g	1-2 Weeks	ȺǊũƎ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1951439-42-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1951439-42-1; Formule moléculaire:C20H21ClN4O; Point de fusion:-; Code SMILES:O=C1NC(N(CC2=CC(Cl)=NC=C2)N=C3C4CCC4)=C3C5=C1CCCC5; Densité:

: Numéro de catalogue:CM228812; Poids moléculaire:368.87; Point d'ébullition:; N° Mdl:MFCD27991334; Stockage:

: Pyrazolopyridines; Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.